A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer
Clinical trial NCT05171777 · COMPLETED
Trial details
- NCT number
- NCT05171777
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-04
- Primary completion
- 2023-11-09
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.